ArticleMedical science monitor : international medical journal of experimental and clinical research2025
C-Reactive Protein, Uric Acid, and Coronary Artery Ectasia in Patients with Coronary Artery Disease.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The expression of C-reactive protein, erythrocyte sedimentation rate, and procalcitonin in children with Kawasaki disease and their correlation with coronary artery ectasia.BMC pediatrics · 2026Article
- Association of Hyperuricemia with Cardiovascular Risk Factors and Cardiac Structural Changes in Patients Undergoing Maintenance Hemodialysis in Southwest China.Medical science monitor : international medical journal of experimental and clinical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Coronary artery ectasia (CAE) is frequently present with coronary artery disease (CAD). However, it is not clear why some patients with CAD progress to CAE while others do not. The pathogenesis of CAE is still poorly elucidated. C-reactive protein (CRP) and serum uric acid are well-known markers of inflammation. We aimed to investigate the possible associations among CRP, uric acid, and CAE in patients with CAD. MATERIAL AND METHODS We retrospectively evaluated data from 2400 patients undergoing coronary angiography. Seventy-four patients with CAE and CAD and 124 patients with only CAD detected on coronary angiography examination were included in this study. Univariate and multivariate logistic regression analyses were performed to evaluate the associated parameters of CAE in patients with CAD. RESULTS Patients with CAE and CAD were younger than patients with only CAD (63±9.5 vs 66.1±9.4, P=0.028). Male sex was more prevalent in patients with CAE and CAD than in patients with only CAD (86.5% vs 74.2%; P=0.029). CRP and uric acid were higher in patients with CAE and CAD compared to the patients with only CAD (10.9±12.8 vs 6.6±6.4; P=0.004; 5.9±1.4 vs 5.2±1.5; P=0.002, respectively). In multivariate regression analysis, age [P=0.029,OR(95% CI) 0.958(0.921-0.996)], CRP [P=0.010,OR (95% CI) 1.058 (1.014-1.103)], and uric acid [P=0.002,OR (95%CI) 1.527 (1.173-1.988)] were associated with CAE in patients with CAD. CONCLUSIONS The CRP and uric acid levels were higher in patients with CAE and CAD compared to the patients who only had CAD. Also, CRP and uric acid were associated with CAE. These results reflect the higher-grade vascular inflammation relative to atherosclerotic involvement in the presence of concomitant CAE in patients with CAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.